logo

Amgen Inc. (AMGN)



Trade AMGN now with
  Date
  Headline
9/12/2022 4:43:49 AM Amgen Announces Updated Data From Phase 1b CodeBreaK 101 Study
9/8/2022 8:48:27 AM Amgen : SPROUT Data Show Otezla Resulted In Improvements In Measures Of Moderate To Severe Plaque Psoriasis
8/29/2022 3:26:46 AM Amgen Presents New Compelling Data From The Phase 3 FOURIER OLE Studies Of Repatha At ESC
8/23/2022 9:06:07 AM Amgen Announces Positive Results From Phase 3 Study Of ABP 959 In Paroxysmal Nocturnal Hemoglobinuria
8/4/2022 4:03:30 PM Amgen Q2 EPS $2.45 Vs. $0.81 Year Ago
8/4/2022 8:02:15 AM Amgen To Buy ChemoCentryx For $52/Shr Cash, Representing An Enterprise Value Of About $3.7 Bln
8/3/2022 4:13:10 PM Amgen Appoints Michael Drake To Its Board Of Directors
8/3/2022 4:02:19 PM Amgen Declares Q3 Dividend Of $1.94/share, Payable Sept. 8/ Record Aug. 18
8/3/2022 4:01:42 PM Amgen Inc. (AMGN) Declares $ 1.94 Dividend for Q3 22, Record Date 8/18/2022